BSE Live
Jan 16, 16:01Prev. Close
1573.10
Open Price
1571.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 16, 15:56Prev. Close
1570.60
Open Price
1575.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1558.50 (586)
| Key Financial Ratios of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 45.71 | 39.03 | 27.00 | 34.00 | |
| Diluted EPS (Rs.) | 45.71 | 39.03 | 27.00 | 34.00 | |
| Cash EPS (Rs.) | 68.67 | 52.20 | 41.93 | 47.23 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 189.93 | 161.95 | 170.76 | 147.08 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 189.93 | 161.95 | 170.76 | 147.08 | |
| Dividend / Share(Rs.) | 15.00 | 10.00 | 4.00 | 4.00 | |
| Revenue from Operations/Share (Rs.) | 449.22 | 360.21 | 369.92 | 348.98 | |
| PBDIT/Share (Rs.) | 127.20 | 76.53 | 68.35 | 68.01 | |
| PBIT/Share (Rs.) | 104.24 | 62.91 | 53.88 | 55.03 | |
| PBT/Share (Rs.) | 48.51 | 44.53 | 30.75 | 38.55 | |
| Net Profit/Share (Rs.) | 45.71 | 38.58 | 27.46 | 34.25 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 28.31 | 21.24 | 18.47 | 19.48 | |
| PBIT Margin (%) | 23.20 | 17.46 | 14.56 | 15.76 | |
| PBT Margin (%) | 10.79 | 12.36 | 8.31 | 11.04 | |
| Net Profit Margin (%) | 10.17 | 10.70 | 7.42 | 9.81 | |
| Return on Networth / Equity (%) | 24.06 | 23.82 | 16.07 | 23.28 | |
| Return on Capital Employed (%) | 38.03 | 23.69 | 18.22 | 22.71 | |
| Return on Assets (%) | 9.86 | 8.14 | 5.62 | 8.52 | |
| Total Debt/Equity (X) | 0.63 | 0.77 | 0.79 | 0.61 | |
| Asset Turnover Ratio (%) | 0.96 | 0.84 | 0.83 | 0.00 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 1.01 | 0.96 | 1.02 | 1.01 | |
| Quick Ratio (X) | 0.61 | 0.60 | 0.68 | 0.69 | |
| Inventory Turnover Ratio (X) | 1.50 | 1.66 | 2.24 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 32.81 | 25.92 | 14.56 | 11.67 | |
| Dividend Payout Ratio (CP) (%) | 21.84 | 19.15 | 9.53 | 8.46 | |
| Earnings Retention Ratio (%) | 67.19 | 74.08 | 85.44 | 88.33 | |
| Cash Earnings Retention Ratio (%) | 78.16 | 80.85 | 90.47 | 91.54 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 67.18 | 74.07 | 85.43 | 88.32 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 |
09.01.2026
07.01.2026
24.12.2025
10.12.2025
17.11.2025
Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y
12.11.2025
Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y